Wu Meei-Maan, Chen Chi-Wei, Chen Chiu-Yi, Lee Chih-Hung, Chou Mark, Hsu Ling-I, Lee Te-Chang, Chen Chien-Jen, 2022, “TIMP3 Gene Polymorphisms of -1296 T > C and -915 A > G Increase the Susceptibility to Arsenic-Induced Skin Cancer: A Cohort Study and In Silico Analysis of Mutation Impacts”, International Journal of Molecular Sciences, 23(23), 14980. (SCIE)
Chiang Chun-Ju, Jhuang Jing-Rong, Yang Ya-Wen, Zhuang Bo-Zhi, You San-Lin, Lee Wen-Chung, Chen Chien-Jen*, 2022, “Association of Nationwide Hepatitis B Vaccination and Antiviral Therapy Programs With End-Stage Liver Disease Burden in Taiwan”, JAMA Network Open, 5(7), e2222367. (SCIE)
Leung Chi Yan, Huang Hsi-Lan, Abe Sarah Krull, Saito Eiko, Islam Md. Rashedul, Rahman Md. Shafiur, Ikeda Ai, Sawada Norie, Tamakoshi Akiko, Gao Yu-Tang, Koh Woon-Puay, Shu Xiao-Ou, Sakata Ritsu, Tsuji Ichiro, Kim Jeongseon, Park Sue K., Nagata Chisato, You San-Lin, Yuan Jian-Min, Shin Myung-Hee, Pan Wen-Harn, Tsugane Shoichiro, Kimura Takashi, Wen Wanqing, Cai Hui, Ozasa Kotaro, Matsuyama Sanae, Kanemura Seiki, Sugawara Yumi, Shin Aesun, Wada Keiko, Chen Chien-Jen, Wang Renwei, Ahn Yoon-Ok, Ahsan Habibul, Boffetta Paolo, Chia Kee Seng, Matsuo Keitaro, Qiao You-Lin, Rothman Nathaniel, Zheng Wei, Kang Daehee, Inoue Manami, 2022, “Association of Marital Status With Total and Cause-Specific Mortality in Asia”, JAMA Network Open, 5(5), e2214181. (SCIE)
Chu Yu-Ju, Jeng Wen-Juei, Pan Mei-Hung, Hu Hui-Han, Luo Wen-Sheng, Su Chien-Yu, Chiang Chen-Tse, Jen Chin-Lan, Chen Chien-Jen, Yang Hwai-I, 2022, “Serum soluble programmed death-1 levels predict the spontaneous HBeAg seroclearance in chronic hepatitis B”, Journal of Gastroenterology, 57(6), 423-432. (SCIE)
Chien-jen Chen, 2022, “How bench work and public service can synergize”, Nature, 603(7900), 203-203. (SCIE)
Wu Hui-Chen, Jeng Wen-Juei, Pan Mei-Hung, Hsieh Yi-Chung, Lu Sheng-Nan, Chen Chien-Jen, Yang Hwai-I., 2022, “Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection”, JHEP Reports, 4(2), 100410. (SCIE)
Lee Sangjun, Jang Jieun, Abe Sarah Krull, Rahman Shafiur, Saito Eiko, Islam Rashedul, Gupta Prakash C, Sawada Norie, Tamakoshi Akiko, Shu Xiao-Ou, Koh Woon-Puay, Sadakane Atsuko, Tsuji Ichiro, Kim Jeongseon, Oze Isao, Nagata Chisato, You San-Lin, Shin Myung-Hee, Pednekar Mangesh S, Tsugane Shoichiro, Cai Hui, Yuan Jian-Min, Wen Wanqing, Ozasa Kotaro, Matsuyama Sanae, Kanemura Seiki, Shin Aesun, Ito Hidemi, Wada Keiko, Sugawara Yumi, Chen Chien-Jen, Ahn Yoon-Ok, Chen Yu, Ahsan Habibul, Boffetta Paolo, Chia Kee Seng, Matsuo Keitaro, Qiao You-Lin, Rothman Nathaniel, Zheng Wei, Inoue Manami, Kang Daehee, Park Sue K, 2022, “Association between body mass index and oesophageal cancer mortality: a pooled analysis of prospective cohort studies with >800 000 individuals in the Asia Cohort Consortium”, International Journal of Epidemiology, 51(4), 1190-1203. (SCIE)
Argirion Ilona, Brown Jalen, Jackson Sarah, Pfeiffer Ruth M., Lam Tram Kim, O’Brien Thomas R., Yu Kelly J., McGlynn Katherine A., Petrick Jessica L., Pinto Ligia A., Chen Chien-Jen, Hildesheim Allan, Yang Hwai-I, Lee Mei-Hsuan, Koshiol Jill, 2022, “Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort”, Cancers, 14(21), 5280. (SCIE)
Coghill Anna E., Fang Jianwen, Liu Zhiwei, Chen Chien-Jen, Jarrett Ruth F., Hjalgrim Henrik, Proietti Carla, Yu Kelly J., Hsu Wan-Lun, Lou Pei-Jen, Wang Chen-Ping, Zhao Yingdong, Doolan Denise L., Hildesheim Allan, 2022, “Identifying Epstein–Barr virus peptide sequences associated with differential IgG antibody response”, International Journal of Infectious Diseases, 114, 65-71. (SCIE)
Chien Li-Hsin, Chen Tzu-Yu, Chen Chung-Hsing, Chen Kuan-Yu, Hsiao Chin-Fu, Chang Gee-Chen, Tsai Ying-Huang, Su Wu-Chou, Huang Ming-Shyan, Chen Yuh-Min, Chen Chih-Yi, Liang Sheng-Kai, Chen Chung-Yu, Wang Chih-Liang, Hung Hsiao-Han, Jiang Hsin-Fang, Hu Jia-Wei, Rothman Nathaniel, Lan Qing, Liu Tsang-Wu, Chen Chien-Jen, Yang Pan-Chyr, Chang I-Shou, Hsiung Chao A., 2022, “Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan”, Cancer Epidemiology, Biomarkers & Prevention, 31(12), 2208-2218.
Hu Hui‐Han, Jeng Wen‐Juei, Pan Mei‐Hung, Luo Wun‐Sheng, Chang Chia‐Ling, Huang Yen‐Tsung, Su Chien‐Yu, Chiang Chen‐Tse, Jen Chin‐Lan, Chien Yu‐Chuan, Lu Shen‐Nan, Wang Li‐Yu, Huang Li‐Rung, Lee Mei‐Hsuan, Liu Jessica, Nguyen Mindie H., Chen Chien‐Jen, Yang Hwai‐I, 2022, “Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B”, Alimentary Pharmacology & Therapeutics, 55(5), 558-567.
Hsiao, Michael
Chan MH, Li CH, Chang YC, Hsiao M*, 2022, “Iron-based Ceramic Composite Nanomaterials for Magnetic Fluid Hyperthermia and Drug Delivery”, PHARMACEUTICS, 1, 1. (SCIE)
Pan KF, Liu YC, Hsiao M, Cheng TY, Hua KT, 2022, “Naa10p Promotes Cell Invasiveness of Esophageal Cancer by Coordinating the c-Myc and PAI1 Regulatory Axis”, CELL DEATH & DISEASE, 13, 995. (SCIE)
Chang WM, Li LJ, Chiu IA, Lai TC, Chang YC, Tsai HF, Yang CJ, Huang MS, Su CY, Lai TL, Jan YH, Hsiao M*, 2022, “The Aberrant Cancer Metabolic Gene Carbohydrate Sulfotransferase 11 Promotes Non-small Cell Lung Cancer Cell Metastasis via Dysregulation of Ceruloplasmin and Intracellular Iron Balance”, TRANSLATIONAL ONCOLOGY, 25, 101508. (SCIE)
Li CH, Chan MH, Chang YC, Hsiao M*, 2022, “The CHST11 Gene Is Linked to Lung Cancer and Pulmonary Fibrosis”, JOURNAL OF GENE MEDICINE, e3451, 1. (SCIE)
Chuang HH, Huang MS, Zhen YY, Chuang CH, Lee YR, Hsiao M*, Yang CJ, 2022, “FAK Executes Anti-Senescence via Regulating EZH2 Signaling in Non-Small Cell Lung Cancer Cells”, BIOMEDICINES, Aug 10;10(8), 1937. (SCIE)
Li LJ, Li CH, Chang PM, Lai TC, Yong CY, Feng SW, Hsiao M, Chang WM, Huang CYF., 2022, “Dehydroepiandrosterone (DHEA) Sensitizes Irinotecan to Suppress Head and Neck Cancer Stem-Like Cells by Downregulation of WNT Signaling”, FRONTIERS IN ONCOLOGY, Jul13;12, 775541. (SCIE)
Chou PC, Liu CM, Weng CH, Yang KC, Cheng ML, Lin YC, Yang RB, Shyu BC, Shyue SK, Liu JD, Chen SP, Hsiao M, Hu YF, 2022, “Fibroblasts Drive Metabolic Reprogramming in Pacemaker Cardiomyocytes [COVER STORY]”, CIRCULATION RESEARCH, June24;131(1), 6-20. (SCIE)
Lai TC, Lee YL, Lee WJ, Hung WY, Cheng GZ, Chen JQ, Hsiao M, Chien MH, Chang JH, 2022, “Synergistic Tumor Inhibition via Energy Elimination by Repurposing Penfluridol and 2-Deoxy-D-Glucose in Lung Cancer”, CANCERS, June 1;14(11), 2750. (SCIE)
Li CH, Chang YC, Hsiao M*, Chan MH, 2022, “Ultrasound and Nanomedicine for Cancer-Targeted Drug Delivery: Screening, Cellular Mechanisms and Therapeutic Opportunities”, PHARMACEUTICS, June 16;14(6), 1282. (SCIE)
Lin CC, Cheng PY, Hsiao M, Liu YP, 2022, “Effects of RU486 in Treatment of Traumatic Stress-Induced Glucocorticoid Dysregulation and Fear-Related Abnormalities: Early versus Late Intervention”, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, May14;23(10), 5494. (SCIE)
Chan MH, Huang WT, Chen KC, Su TY, Chan YC, Hsiao M*, Liu RS, 2022, “The Optical Research Progress of Nanophosphors Composed of Transition Elements in the Fourth Period of Near-infrared Windows I and II for Deep-tissue Theranostics [COVER STORY]”, NANOSCALE, May21;14(19), 7123-7136. (SCIE)
Chan MH, Chang ZX, Huang CYF, Lee LJ, Liu RS, Hsiao M*, 2022, “Integrated Therapy Platform of Exosomal System: Hybrid Inorganic/Organic Nanoparticles with Exosomes for Cancer Treatment [COVER STORY]”, NANOSCALE HORIZONS, 7(4), 352-367. (SCIE)
Chang YC, Li C, Chan MH, Chen MH, Yeh CN, Hsiao M*, 2022, “Regorafenib Inhibits Epithelial-mesenchymal Transition and Suppresses Cholangiocarcinoma Metastasis via YAP1-AREG Axis”, CELL DEATH & DISEASE, 13(4), 391. (SCIE)
Tung MC, Lin YW, Lee WeJ, Wen YC, Liu YC, Chen JQ, Hsiao M, Yang YC, Chien MH, 2022, “Targeting DRD2 by the Antipsychotic Drug, Penfluridol, Retards Growth of Renal Cell Carcinoma via Inducing Stemness Inhibition and Autophagy-mediated Apoptosis”, CELL DEATH & DISEASE, Apr23;13(4), 400. (SCIE)
Wen YC, Liu CL, Yeh HL, Chen WH, Jiang KC, Tram VTN, Hsiao M, Huang J, Chen WY, Liu YN, 2022, “PCK1 Regulates Neuroendocrine Differentiation in A Positive Feedback Loop of LIF/ZBTB46 Signalling in Castration-resistant Prostate Cancer”, BRITISH JOURNAL OF CANCER, 126(5), 778-790. (SCIE)
Wen YC, Chen WY, Tram VTN, Yeh HL, Chen WH, Jiang KC, Abou-Kheir W, Huang J, Hsiao M, Liu YN, 2022, “Pyruvate Kinase L/R Links Metabolism Dysfunction to Neuroendocrine Differentiation of Prostate Cancer by ZBTB10 Deficiency”, CELL DEATH & DISEASE, 13(3), 252. (SCIE)
Chuang HH, Zhen YY, Tsai YC, Chuang CH, Hsiao M, Huang MS, Yang CJ, 2022, “FAK in Cancer: From Mechanisms to Therapeutic Strategies”, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Feb 2;23(3), 1726. (SCIE)
Li LJ, Chang PM, Li CH, Lai TC, Chang YC, Su CY, Chen CL, Chang WM, Hsiao M*, Fung SW, 2022, “FAS Receptor Regulates NOTCH Activity through ERK-JAG1 Axis Activation and Controls Oral Cancer Stemness Ability and Pulmonary Metastasis”, CELL DEATH DISCOVERY, In Press, 1. (SCIE)
Chan MH, Huang WT, Satpathy A, Su TY, Hsiao M*, Liu RS, 2022, “Progress and Viewpoints of Multifunctional Composite Nanomaterials for Glioblastoma Theranostics”, PHARMACEUTICS, Feb 21;(14), 459. (SCIE)
Chang YC, Chang PM, Li CH, Chan MH, Lee YJ, Chen MH, Hsiao M*, 2022, “Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung Cancer.”, FRONTIERS IN ONCOLOGY, Jan 21;11, 811635. (SCIE)
Chan MH, Huang WT, Hsiao M*, Liu RS, 2022, “Design Growth of Nanophosphors and Their Applications”, editor(s): Liu Ru-Shi, Wang Xiao-Jun, Phosphor Handbook: Experimental Methods for Phosphor Evaluation and Characterization, pp. Jan 31: 333-362, United States: CRC PRESS, TAYLOR & FRANCIS GROUP.
Chou CC, Hua KT, Chen MW, Wu CJ, Hsu CH, Wang JT, Hsiao M, Wei LH, 2022, “Discovery and Characterization of A Monoclonal Antibody Targeting A Conformational Epitope of IL-6/IL-6Rα to Inhibit IL-6/ IL-6Rα/gp130 Hexameric Signaling Complex Formation”, MABS, 14(1), 2029675. (SCIE)
Chang ZX, Li CH, Chang YC, Huang CYF, Chan MH, Hsiao M*, 2022, “Novel Monodisperse FePt Nanocomposites for T2-weighted Magnetic Resonance Imaging: Biomedical Theranostics Applications [COVER STORY]”, NANOSCALE ADVANCES, Jan 21;4(2), 377-386. (SCIE)
Tsai MT, Sun YS, Keerthi M, Panda AK, Dhawan U, Chang YH, Lai CF, Hsiao M, Wang HY, Chung RJ, 2022, “Oral Cancer Theranostic Application of FeAu Bimetallic Nanoparticles Conjugated with MMP-1 Antibody”, NANOMATERIALS, 12(1), 61. (SCIE)
Li Chien-Hsiu, Chan Ming-Hsien, Liang Shu-Mei, Chang Yu-Chan, Hsiao Michael, 2022, “Fascin-1: Updated biological functions and therapeutic implications in cancer biology”, BBA Advances, 2, 100052. (SCIE)
Lin EH, Hsu JW, Lee TF, Hsu CF, Lin TH, Jan YH, Chang HY, Cheng CM, Hsu HJ, Chen WW, Chen BH, Tsai HF, Li JJ, Huang CY, Chuang SH, Chang JM, Hsiao M, Wu CW, 2022, “Targeting cancer stemness mediated by BMI1 and MCL1 for non-small cell lung cancer treatment.”, JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 26(15), 4305-4321. (SCIE)
Hsieh, Shie-Liang
Sung PS, Peng YC, Yang SP, Chiu CH, Hsieh SL*, 2022, “CLEC5A is critical in Pseudomonas aeruginosa-induced NET formation and acute lung injury”, JCI INSIGHT, 7(18), e156613. (SCIE)
Sung PS, Yang SP, Perng YC, Sun CP, Tao MH, Hsieh SL*, 2022, “CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation”, JOURNAL OF BIOMEDICAL SCIENCE, 29(1), 52. (SCIE)
Weng SC, Wen MC, Hsieh SL, Chen NJ, Tarng DC*, 2022, “Decoy Receptor 3 Suppresses T-Cell Priming and Promotes Apoptosis of Effector T-Cells in Acute Cell-Mediated Rejection: The Role of Reverse Signaling”, FRONTIERS IN IMMUNOLOGY, 13, 879648. (SCIE)
Hsu YW, Huang H CH, Huang WC, Yeh YH, Hsiao CD, Chang WC**, Hsieh SL**, 2022, “Human rs75776403 Polymorphism Links Differential Phenotypic and Clinical Outcomes to a CLEC18A p.T151M-Driven Multiomics”, JOURNAL OF BIOMEDICAL SCIENCE, 29(1), 43. (SCIE)
Wu YH, Mo ST, Chen IT, Hsieh FY, Hsieh SL, Zhang J, Lai MZ, 2022, “Caspase-8 inactivation drives autophagy-dependent inflammasome activation in myeloid cells.”, Science advances, 8(45), eabn9912. (SCIE)
Wu NL, Huang DY, Hsieh SL, Dai YS, Lin WW, 2022, “Decoy receptor 3 is involved in epidermal keratinocyte commitment to terminal differentiation via EGFR and PKC activation.”, Experimental & molecular medicine, 54(4), 542-551. (SCIE)
Hwang-Verslues, Wendy W.
Wang Cheng-Kai, Chen Tzu-Jou, Tan Grace Y.T., Chang Fang-Pei, Sridharan Samyuktha, Yu Chen-Hsin Albert., Chang Yen-Hou, Chen Yi-Jen, Cheng Li-Tzu, Hwang-Verslues Wendy W.*, 2022, “MEX3A mediates p53 degradation to suppress ferroptosis and facilitate ovarian cancer tumorigenesis”, Cancer Research, https://doi.org/10.1158/0008-5472.CAN-22-1159, https://doi.org/10.1158/0008-5472.CAN-22-1159. (SCIE)
Lin, Kuo-I
Wu, J.-L., Wu, H.-Y., Wu, S.-J., Tsai, H.-Y., Weng, S.-H., Lin, K.-T., Lin, L.-I., Yao, C.-Y., Zamanova, M., Lee, Y.-Y., Angata, T., Tien, H.-F., Chen, Y.-J.* and Lin, K.-I*, 2022, “Phosphoproteomics reveals the role of constitutive KAP1 phosphorylation by B-cell receptor signaling in chronic lymphocytic leukemia”, Molecular Cancer Research, https://doi.org/10.1158/1541-7786., MCR-21-0722. (SCIE)
Chang, L.-Y., Liang, S.-Y., Lu, S.-C., Tseng, H.-C., Tsai, H.-Y., Tang, C.-J., Sugata, M., Chen, Y.-J., Chen, Y. -J. Wu, S.-J., Lin, K.-I, Khoo, K.-H., and Angata, T., 2022, “Molecular basis and role of Siglec-7 ligand expression on chronic lymphocytic leukemia B cells”, Frontiers in Immunology, 13, 840388. (SCIE)
Gebreyesus, S. T., Siyal, A. A., Kitata, R. B., Chen, S.-W., Enkhbayar, B., Angata, T., Lin, K.-I, Chen, Y.-J. and Tu., S.-L., 2022, “Streamlined single-cell proteomics by an integrated microfluidic chip and data-independent acquisition mass spectrometry”, NATURE COMMUNICATIONS, 13(1), 37. (SCIE)
Lu, Joyce Jean
Lai PL, Ng CH, Wu CH, Lai CY, Schuyler SC, Wang V, Lin H, Lee YC, Chuang MH, Yang CH, Chen WJ, Huang HC, Lu J*, 2022, “Development of a Chemical Cocktail That Rescues Mouse Brain Demyelination in a Cuprizone-Induced Model.”, Cells, 11(7), 1091. (SCIE)
Yadav A, Ramasamy TS, Lin SC, Chen SH, （Lu J）, Liu YH, Lu FI, Hsueh YY, Lin SP, Wu CC, 2022, “Autologous Platelet-Rich Growth Factor Reduces M1 Macrophages and Modulates Inflammatory Microenvironments to Promote Sciatic Nerve Regeneration.”, Biomedicines, 10(8), 1991. (SCIE)
Shen, Chia-Ning
C.W. Lee, C.C. Kuo, C.J. Liang , H.J. Pan, C.N. Shen*, C.H. Lee*, 2022, “Effects of the media conditioned by various macrophage subtypes derived from THP-1 cells on tunneling nanotube formation in pancreatic cancer cells”, BMC Molecular and Cell Biology, 23(1), 26. (SCIE)
Khamushavalli, G., Guo, J.Y., C.N. Shen, J.K. Jiang, C.S.J. Fann, M.J. Hwang, J.W. Shui, H.T. Lin, M.J. Wang, H.C. Shih, A. F.Y. Li, S.C. Chang, S.H. Yang*, and J.Y. Chen*., 2022, “Patient-derived organoids serves as a platform for personalized chemotherapy in advanced colorectal cancer patients.”, Frontiers in Oncology, 12, 883437. (SCIE)
W.A. Chen, Y.H. Chen, C.Y. Hsieh, P.F. Hung, C.W. Chen, C.H. Chen, J.L. Lin, T.J. R. Cheng, T.L. Hsu, Y.T. Wu, C.N. Shen* and W.C. Cheng*., 2022, “Harnessing Natural-Product-Inspired Combinatorial Chemistry and Computation-Guided Synthesis to Develop N-Glycan Modulators as Anticancer Agents.”, Chemical Science, 13, 6233-6243. (SCIE)
Hsu, F. C., H.L. Lee, Y.J. Chen, Y.A. Shen, M.H. Wu, W.S. Huang, Y.C. Tsai, S.D. Yeh, C.C. Kuo, L.S. Lu, C.N. Shen* and J.F. Chiou*, 2022, “A Few-Shot Learning Approach Assists in the Prognosis Prediction of Magnetic Resonance-Guided Focused Ultrasound for the Local Control of Bone Metastatic Lesions”, Cancers, 12, 445. (SCIE)
Peng CW, Jeng WJ, Yang HI, Liu YC, Chien RN, Liaw YF, 2022, “A switch from tenofovir to entecavir prior to hepatitis B treatment cessation is associated with a reduced risk of off-therapy relapse: An observational study.”, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 37(11), 2164-2172. (SCIE)
Argirion I, Brown J, Jackson S, Pfeiffer RM, Lam TK, O'Brien TR, Yu KJ, McGlynn KA, Petrick JL, Pinto LA, Chen CJ, Hildesheim A, Yang HI, Lee MH, Koshiol J, 2022, “Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort.”, Cancers, 14(21), 5280-doi: 10.3390/cancers14215280. (SCIE)
Tai AS, Huang YT, Yang HI, Lan LV, Lin SH, 2022, “G-Computation to Causal Mediation Analysis With Sequential Multiple Mediators-Investigating the Vulnerable Time Window of HBV Activity for the Mechanism of HCV Induced Hepatocellular Carcinoma.”, FRONTIERS IN PUBLIC HEALTH, 9, 757942. (SCIE, SSCI) (IF: 6.461; SCI ranking: 17.6%; SSCI ranking: 9.8%)
Wu HC*, Jeng WJ, Pan MH, Hsieh YC, Lu SN, Chen CJ, Yang HI*, 2022, “Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection.”, JHEP Reports, 4(2), 100410-doi: 10.1016/j.jhepr. (SCIE)
Wen-Juei Jeng, Mei-Hung Pan, Hwai-I Yang*, 2022, “Letter: sPD‐1 as a predictor for HBsAg seroconversion—shed light on inactive carriers with chronic hepatsitis B. Authors' reply”, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 55(8), 1057-1058. (SCIE)
Huang DQ, Li X, Le MH, Le AK, Yeo YH, Trinh HN, Zhang J, Li J, Wong C, Wong C, Cheung RC, Yang HI*, Nguyen MH*, 2022, “Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis B Patients with Indeterminate Phase”, CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 20(8), 1803-1812. (SCIE)
Park J, Le AK, Tseng TC, Yeh ML, Jun DW, Trinh H, Wong GLH, Chen CH, Peng CY, Kim SE, Oh H, Kwak MS, Cheung KS, Toyoda H, Hsu YC, Jeong JY, Yoon EL, Ungtrakul T, Zhang J, Xie Q, Ahn SB, Enomoto M, Shim JJ, Cunningham C, Jeong SW, Cho YK, Ogawa E, Huang R, Lee DH, Takahashi H, Tsai PC, Huang CF, Dai CY, Tseng CH, Yasuda S, Kozuka R, Li J, Wong C, Wong CC, Zhao C, Hoang J, Eguchi Y, Wu C, Tanaka Y, Gane E, Tanwandee T, Cheung R, Yuen MF, Lee HS, Yu ML, Kao JH, Yang HI, Nguyen MH, 2022, “Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.”, CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 20(4), 874-885. (SCIE)
Hu HH, Jeng WJ, Pan MH, Luo WS, Chang CL, Huang YT, Su CY, Chiang CT, Jen CL, Chien YC, Lu SN, Wang LY, Huang LR, Lee MH, Liu J, Nguyen MH, Chen CJ, Yang HI*, 2022, “Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B.”, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 55(5), 558-567. (SCIE)
Chu YJ, Jeng WJ, Pan MH, Hu HH, Luo WS, Su CY, Chiang CT, Jen CL, Chen CJ, Yang HI*, 2022, “Serum soluble programmed death-1 levels predict the spontaneous HBeAg seroclearance in chronic hepatitis B.”, JOURNAL OF GASTROENTEROLOGY, 57(6), 423-432. (SCIE)
Feng YA, Chen CY, Chen TT, Kuo PH, Hsu YH, Yang HI, Chen WJ, Su MW, Chu HW, Shen CY, Ge T, Huang H, Lin YF, 2022, “Taiwan Biobank: A rich biomedical research database of the Taiwanese population.”, Cell Genomics, 2(11), 100197.
Jeng Wen-Juei*, Chen Chien-Hung*, Wang Yi-Wen, Pan Mei-Hung, Lin Chia-Wei, Lin Chun-Yen, Yang Hwai-I*, 2022, “The association between sPD-1 levels versus liver biochemistry and viral markers in chronic hepatitis B patients: a comparative study of different sPD-1 assays”, VIROLOGY JOURNAL, 19(1), 59-10.1186/s12985-022-0. (SCIE)